Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways

Oncology Reports

Volumn 20, Issue 4, 2008, Pages 819-824

  Gao, Jian Li ^a   Shi, Jun Min ^a   He, Kai ^b   Zhang, Qing Wen ^a   Li, Shao Ping ^a   Lee, Simon Ming Yuen ^a   Wang, Yi Tao ^a  

^a University of Macau   (Macao)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast cancer; Cell invasion; Corydalis yanhusuo; Metalloproteinases; Mitogen activated protein kinase

Indexed keywords

CORYDALIS YANHUSUO EXTRACT; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CORYDALIS; CORYDALIS YANHUSUO; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS INHIBITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CORYDALIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MEDICINE, CHINESE TRADITIONAL; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS;

EID: 54949114297     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000079     Document Type: Article

References (21)

1. Wu QP, Xie YZ, Li SZ, La Pierre DP, Deng ZQ, Chen Q, Li C, Zhang Z, Guo J, Wong CK, Lee DY, Yee A and Yang BB: Tumour cell adhesion and integrin expression affected by Ganoderma lucidum. Enzyme Microb Technol 40: 32-41, 2006.
2. Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC and Lee IS: Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem Biophys Res Commun 354: 165-171, 2007.
3. Lee WJ, Wu LF, Chen WK, Wang CJ and Tseng TH: Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact 160: 123-133, 2006.
4. Huang Q, Shen HM and Ong CN: Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-κB. Biochem Pharmacol 68: 361-371, 2004.
5. Chinese Pharmacopoeia Commission (ed.) Pharmacopoeia of the People's Republic of China. Chemical Industry Press, Beijing, p94, 2005.
6. He K, Gao JL and Zhao GS: Advances in studies on chemistry, pharmacology and quality control of Corydalis YHS. Zhong Cao Yao 38: 11-14, 2007.
7. Zhang ZM, Jiang B and Zheng XX: Effect of 1-tetrahydro-palmatine on expression of adhesion molecules induced by lipopolysaccharides in human umbilical vein endothelium cell. Chin J Chinese Materia Medica 30: 861-864, 2004.
8. He L and Liu GQ: Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacol Sin 23: 423-429, 2002.
9. Letasiová S, Jantová S, Cipák L and Múcková M: Berberine-antiproliferative activity in vitro and induction of apoptosis/ necrosis of the U937 and B16 cells. Cancer Lett 239: 254-262, 2006.
10. Peng PL, Hsieh YS, Wang CJ, Hsu JL and Chou FP: Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 214: 8-15, 2006.
11. Wu HL, Hsu CY, Liu WH and Yung YM: Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/ B23 and telomerase activity. Int J Cancer 81: 923-929, 1999.
12. Sanders MM, Liu A, Li TK, Wu HY, Desai SD, Mao Y, Rubin EH, LaVoie EJ, Makhey D and Liu LF: Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells. Biochem Pharmacol 56: 1157-1166, 1998.
13. Hu J, Speisky W and Cotgreave IA: The inhibitory effects of boldine, glaucine, and probucol on TPA-induced down regulation of gap junction function. Biochem Pharmacol 50: 1635-1643, 1995.
14. Tao YW and Tian GY: Studies on the physicochemical properties, structure and antitumor activity of polysaccharide YhPS-1 from the root of Corydalis yanhusuo Wang. Chin J Chem 24: 235-239, 2006.
15. Sa F, Gao JL, Fung KP, Zheng Y, Lee MY and Wang YT: Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines. Chem Biol Interact 171: 1-14, 2008.
16. Lam HW, Lin HC, Lao SC, Gao JL, Hong SJ, Yue YK, Kwan YW, Leong CW, Leung YH, Lee MY and Wang YT: The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. J Cell Biochem 103: 195-211, 2008.
17. Bartsch JE, Staren ED and Appert FIE: Matrix metalloproteinase expression in breast cancer. J Surg Res 110: 383-392, 2003.
18. Kaneshiro T, Morioka T, Inamine M, Kinjo T, Arakaki J, Chiba I, Sunagawa N, Suzui M and Yoshimi N: Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. Eur J Pharmacol 553: 46-53, 2006.
19. Mitani N, Murakami K, Yamaura T, Ikeda T and Saiki I: Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Cancer Lett 165: 35-42, 2001.
20. Reddy KB, Krueger JS, Kondapaka SB and Diglio CA: Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 82: 268-273, 1999.
21. Simon C, Simon M, Vucelic G, Hicks MJ, Plinkert PK, Koitschev A and Zenner HP: The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-l-dependent promotor activation. Exp Cell Res 271:344-355, 2001.